GAITHERSBURG, Md., Oct. 21, 2019 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS) today announced that the company will host an analyst and investor day on November 21, 2019 in New York City. This event, which is designed for sellside research analysts and institutional investors, will begin at 8:00 AM EST and end at 2:00 PM EST.
Institutional and analyst attendees who choose to participate onsite must register, as space is limited. To register for onsite participation at the event or for more information, please contact Robert Burrows, IRO for Emergent BioSolutions at email@example.com or (240) 631-3280.
Emergent’s senior management will provide a detailed overview of the company’s 2020-2024 Growth Strategy. Presenters include President and CEO, Robert G. Kramer; EVP, Business Operations, Adam Havey; EVP Corporate Development and General Counsel, Atul Saran; EVP and CFO, Richard Lindahl; and the heads of Emergent’s four business units.
Lunch will be provided following the completion of the formal portion of the event.
A live audio-only webcast of the formal portion of the event as well as presentation materials will be available on the Investor Relations homepage of the company’s website at https://investors.emergentbiosolutions.com/. The audio and accompanying presentations will be archived on the company’s website after completion of the event.
Click here to read the entire Press Release.